Schedule 13G ownership disclosure

Amicus Therapeutics Inc

Security class unavailable · CUSIP: 03152W109

Event date: 2023-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,190,024
Percent of class
5.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-24-000043
Form type
SC 13G
Filer
AMICUS THERAPEUTICS, INC.
CIK
CIK 1178879
Filed
Feb 08, 2024
Reporting period
Dec 29, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub